Richard B. Baxter - 02 Jul 2025 Form 4 Insider Report for Pelthos Therapeutics Inc. (CHRO)

Role: Director
Signature: /s/ Richard Baxter
Issuer symbol: CHRO
Transactions as of: 02 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 07 Jul 2025, 21:47:34 UTC
Previous filing: 07 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Baxter Richard B	Director	C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM	/s/ Richard Baxter	07 Jul 2025	0002075922

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTHS	Restricted Stock Units	Award		+19,108			19,108	02 Jul 2025	Common Stock	19,108	$13.50	Direct	F1
transaction	PTHS	Stock Option	Award		+58,230			58,230	02 Jul 2025	Common Stock	58,230	$13.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 19,108 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis thereafter over a period of three (3) years.
F2	On July 2, 2025, the Reporting Person was granted stock options to purchase 58,230 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis thereafter over a period of three (3) years.